Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers August 18, 2017
Pharmacy Choice - Pharmaceutical News - ACHP Shares Support for CHRONIC Care Act of 2017 - August 18, 2017

Pharmacy News Article

 5/19/17 - ACHP Shares Support for CHRONIC Care Act of 2017

WASHINGTON, May 18 The Alliance of Community Health Plans issued the following news release:

The Alliance of Community Health Plans (ACHP) has shared support for the CHRONIC Care Act of 2017, being marked up in the Senate Finance Committee today.

ACHP members are non-profit organizations that provide coverage and care for more than 18 million Americans across 27 states and the District of Columbia, including 2.4 million Medicare beneficiaries. ACHP believes the CHRONIC Care Act of 2017 makes important changes to the Medicare program that will encourage innovative and cost effective approaches to patient care delivery and ultimately improve health outcomes. ACHP stands behind provisions in the CHRONIC Care Act that would permanently reauthorize special needs plans, expand the Medicare Advantage (MA) Value-Based Insurance Design Model and expand supplemental benefits to meet the needs of chronically ill MA enrollees.

"We are grateful to the Senate Finance Committee and the Chronic Care Working Group for its commitment to improve the care of Medicare beneficiaries with chronic conditions," said ACHP President and CEO Ceci Connolly. "ACHP believes strongly in the effectiveness of telehealth and encourages Senators to reconsider language in the bill that may be unnecessarily limiting to the capabilities and reach of telehealth services so that we can work together to improve health and lower costs."

In addition to highlighting the continual innovation in telehealth, ACHP's letter also shares suggested changes to the language on quality star ratings, sharing concerns about the discretion given to the Secretary of HHS in implementing the quality star ratings at the plan level for special needs plans and MA plans. The letter states:

"Applying the star ratings at the plan level instead of the contract level would cause beneficiary and market confusion when plans have several benefit packages in the same area. Reporting of data at the plan level will lead to small denominators for smaller, community plans like ACHP members and could cause unwarranted variations in ratings."

ACHP Member and UPMC Health Plan representative John Lovelace delivered testimony at Tuesday's hearing on the CHRONIC Care Act of 2017. In his testimony, Lovelace spoke about UPMC's role as a payer-provider, their successful results from UPMC's implementation of Medicare Advantage Value-Based Insurance Design (VBID), and the value of Special Needs Plans (SNPs) and promise of telehealth systems. To access the written testimony of John Lovelace, click here (https://www.finance.senate.gov/imo/media/doc/20170616LovelaceStmt.pdf).

To access the full ACHP letter, click here (http://www.achp.org/wp-content/uploads/ACHP-Letter-Chronic-Care-CC-Signature-5-16-17.pdf).



Targeted News Service

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

LIVE ONLINE CE

Aug 21: An Integrative Approach to Managing Arthritis
Aug 22: Men's Health
Aug 23: Biosimilar Drugs: Legal, Regulatory & Safety Considerations
Aug 24: Treatment of Parkinson's Disease and Comorbid Conditions
Aug 25: NSAIDs, Acetaminophen and Adjuvants in Pain Management
Click for entire Webinar Calendar

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...

Nursing Jobs
Are you a nurse looking for a job?

Check out the Nursing Job Source.

Your number one choice for nursing jobs.



Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415